1. Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms. Issue 6 (2nd June 2016) Authors: Ye, Xing-Nong; Zhou, Xin-Ping; Wei, Ju-Ying; Xu, Gai-Xiang; Li, Ying; Mao, Li-Ping; Huang, Jian; Ren, Yan-Ling; Mei, Chen; Wang, Jing-Han; Lou, Yin-Jun; Ma, Li-Ya; Yu, Wen-Juan; Ye, Li; Xie, Li-Li; Luo, Yin-Wan; Hu, Chao; Niu, Lin-Mei; Dou, Min-Hua; Jin, Jie Journal: Leukemia & lymphoma Issue: Volume 57:Issue 6(2016:Jun.) Page Start: 1311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗